333638801	333638801	CD	B-NP	O
|	|	NN	I-NP	O
TFRMC	TFRMC	NN	I-NP	O
|	|	NN	I-NP	O
08202666	08202666	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
2008759	2008759	CD	B-NP	O
|	|	CC	I-NP	O
5/4/2005	5/4/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CORONARY	CORONARY	NNP	I-NP	I-protein
ARTERY	ARTERY	NNP	I-NP	I-protein
DISEASE	DISEASE	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/10/2005	9/10/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/2/2005	10/2/2005	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
REMIS	REMIS	NN	B-NP	B-protein
,	,	,	O	O
MORRIS	MORRIS	NNP	B-NP	O
MD	MD	NNP	I-NP	O
ADDENDUM	ADDENDUM	NNP	I-NP	O
:	:	:	O	O
DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Include	Include	NN	B-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Tylenol	Tylenol	NN	B-NP	O
650	650	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
4h	4h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	RB	B-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

Amiodarone	Amiodarone	NN	B-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Enteric-coated	Enteric-coated	JJ	B-NP	O
aspirin	aspirin	NN	I-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Dulcolax	Dulcolax	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
PR	PR	NN	I-NP	O
every	every	DT	B-NP	O
other	other	JJ	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
6	6	CD	I-NP	O
.	.	.	O	O

Folate	Folate	NN	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Haldol	Haldol	NN	B-NP	O
0.25	0.25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
medication	medication	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
used	use	VBN	I-VP	O
sparingly	sparingly	RB	B-ADVP	O
as	as	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
gets	get	VBZ	B-VP	O
oversedated	oversedate	VBN	I-VP	O
easily	easily	RB	B-ADVP	O
.	.	.	O	O

Do	Do	VBP	B-VP	O
not	not	RB	I-VP	O
give	give	VB	I-VP	O
over	over	IN	B-PP	O
Haldol	Haldol	NN	B-NP	O
0.25	0.25	CD	I-NP	O
mg	mg	NN	I-NP	O
at	at	IN	B-PP	O
one	one	CD	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Insulin	Insulin	NN	B-NP	B-protein
regular	regular	JJ	I-NP	O
sliding	slide	VBG	I-NP	O
scale	scale	NN	I-NP	O
subcutaneous	subcutaneous	JJ	I-NP	O
a.c.	a.c.	NN	I-NP	O
and	and	CC	B-PP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Lactulose	Lactulose	RB	B-NP	O
30	30	CD	I-NP	O
mL	mL	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.i.d.	q.i.d.	FW	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
for	for	IN	B-PP	O
constipation	constipation	NN	B-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Protonix	Protonix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Synthroid	Synthroid	JJ	B-NP	O
25	25	CD	I-NP	O
mcg	mcg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

Lisinopril	Lisinopril	NNP	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

Metamucil	Metamucil	NN	B-NP	O
sugar	sugar	NN	I-NP	O
free	free	JJ	I-NP	O
one	one	CD	I-NP	O
packet	packet	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

14	14	CD	B-NP	O
.	.	.	O	O

Simvastatin	Simvastatin	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
.	.	.	O	O

15	15	CD	B-NP	O
.	.	.	O	O

Toprol	Toprol	NN	B-NP	O
XL	XL	NN	I-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
hold	hold	VBP	B-VP	O
if	if	IN	B-SBAR	O
systolic	systolic	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
100	100	CD	B-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
55	55	CD	B-NP	O
.	.	.	O	O

16	16	CD	B-NP	O
.	.	.	O	O

Diltiazem	Diltiazem	NNP	B-NP	O
extended	extend	VBD	B-VP	O
release	release	NN	B-NP	O
360	360	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
hold	hold	VBP	B-VP	O
if	if	IN	B-SBAR	O
systolic	systolic	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
100	100	CD	B-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
55	55	CD	B-NP	O
.	.	.	O	O

17	17	CD	B-NP	O
.	.	.	O	O

Plavix	Plavix	NN	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
this	this	DT	B-NP	O
medication	medication	NN	I-NP	O
should	should	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
held	hold	VBN	I-VP	O
for	for	IN	B-PP	O
any	any	DT	B-NP	O
reason	reason	NN	I-NP	O
.	.	.	O	O

18	18	CD	B-NP	O
.	.	.	O	O

Maalox	Maalox	DT	B-NP	O
chewable	chewable	JJ	I-NP	O
1-2	1-2	CD	I-NP	O
tablets	tablet	NNS	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.	q.	FW	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	JJ	B-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Upon	Upon	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
transported	transport	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Ardsdo	Ardsdo	NNP	I-NP	O
Crestver	Crestver	NNP	I-NP	O
Nai	Nai	NNP	I-NP	O
Memorial	Memorial	NNP	I-NP	O
Health	Health	NNP	I-NP	O
Centers	Center	NNPS	I-NP	O
where	where	WRB	B-ADVP	O
he	he	PRP	B-NP	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
physical	physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
,	,	,	O	O
occupational	occupational	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
continued	continued	JJ	B-NP	O
medication	medication	NN	I-NP	O
titration	titration	NN	I-NP	O
.	.	.	O	O

Upon	Upon	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
tolerating	tolerate	VBG	B-VP	O
p.o.	p.o.	FW	B-NP	O
intake	intake	FW	I-NP	O
well	well	RB	B-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
ambulating	ambulate	VBG	I-VP	O
with	with	IN	B-PP	O
minimal	minimal	JJ	B-NP	O
assistance	assistance	NN	I-NP	O
.	.	.	O	O

FOLLOW-UP	FOLLOW-UP	JJ	B-NP	O
APPOINTMENT	APPOINTMENT	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
follow-up	follow-up	JJ	B-NP	O
appointment	appointment	NN	I-NP	O
scheduled	schedule	VBN	B-VP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Seltz	Seltz	NNP	I-NP	O
on	on	IN	B-PP	O
9/10/05	9/10/05	CD	B-NP	O
at	at	IN	B-PP	O
8	8	CD	B-NP	O
:	:	:	O	O
50	50	CD	B-NP	O
a.m.	a.m.	RB	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Okuda	Okuda	NNP	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
Internal	Internal	NNP	I-NP	O
Medicine	Medicine	NNP	I-NP	O
physician	physician	NN	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
7/9/05	7/9/05	CD	B-NP	O
at	at	IN	B-PP	O
9	9	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Ionescu	Ionescu	NNP	I-NP	O
on	on	IN	B-PP	O
4/4/05	4/4/05	CD	B-NP	O
at	at	IN	B-PP	O
9	9	CD	B-NP	O
:	:	SYM	O	O
30	30	CD	B-NP	O
a.m.	a.m.	NN	I-NP	O
TO	TO	TO	B-VP	O
DO	DO	NN	I-VP	O
:	:	:	O	O
Includes	Include	VBZ	B-VP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
have	have	VB	I-VP	O
his	his	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
checked	check	VBD	B-VP	O
everyday	everyday	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
was	be	VBD	B-VP	O
initiated	initiate	VBN	I-VP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
on	on	IN	B-PP	O
7/18/05	7/18/05	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
dosage	dosage	NN	I-NP	O
may	may	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
titrated	titrate	VBN	I-VP	O
in	in	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
keep	keep	VB	I-VP	O
an	an	DT	B-NP	O
INR	INR	NN	I-NP	B-protein
between	between	IN	B-PP	O
a	a	DT	B-NP	O
goal	goal	NN	I-NP	O
of	of	IN	B-PP	O
2-3	2-3	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
aggressive	aggressive	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
regimen	regimen	NN	I-NP	O
to	to	TO	B-VP	O
avoid	avoid	VB	I-VP	O
constipation	constipation	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
have	have	VB	I-VP	O
daily	daily	JJ	B-NP	O
weights	weight	NNS	I-NP	O
checked	check	VBD	B-VP	O
,	,	,	O	O
he	he	PRP	B-NP	O
may	may	MD	B-VP	O
require	require	VB	I-VP	O
additional	additional	JJ	B-NP	O
diuresis	diuresis	NN	I-NP	O
if	if	IN	B-SBAR	O
he	he	PRP	B-NP	O
shows	show	VBZ	B-VP	O
symptoms	symptom	NNS	B-NP	O
of	of	IN	B-PP	O
volume	volume	NN	B-NP	O
overload	overload	NN	I-NP	O
including	include	VBG	B-PP	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
greater	great	JJR	B-NP	O
than	than	IN	I-NP	O
2	2	CD	I-NP	O
pounds	pound	NNS	I-NP	O
weight	weight	NN	I-NP	O
gain	gain	NN	I-NP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
day	day	NN	I-NP	O
or	or	CC	O	O
5	5	CD	B-NP	O
pounds	pound	NNS	I-NP	O
weight	weight	NN	I-NP	O
gain	gain	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
week	week	NN	I-NP	O
or	or	CC	O	O
shows	show	VBZ	B-VP	O
symptoms	symptom	NNS	B-NP	O
of	of	IN	B-PP	O
volume	volume	NN	B-NP	O
overload	overload	NN	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
respiratory	respiratory	JJ	B-NP	O
distress	distress	NN	I-NP	O
or	or	CC	O	O
increasing	increase	VBG	B-VP	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Papay	Papay	NNP	I-NP	O
for	for	IN	B-PP	O
Cardiology	Cardiology	NNP	B-NP	O
followup	followup	NN	I-NP	O
on	on	IN	B-PP	O
9/10/05	9/10/05	CD	B-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
8-6679448	8-6679448	CD	B-NP	O
EMSSten	EMSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
CARDENAS	CARDENAS	NNP	B-NP	O
,	,	,	O	O
ABEL	ABEL	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
WOERNLE	WOERNLE	NNP	B-NP	O
,	,	,	O	O
RAYMUNDO	RAYMUNDO	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
9938519	9938519	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
7/7/05	7/7/05	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
7/7/05	7/7/05	CD	B-NP	O

